<p>The data are presented as the means ± SD or percentages</p><p>Patient baseline characteristics according to CD14 rs2569190 genotype.</p
<p>Baseline characteristics for the patients in the <5 drugs and ≥5 drugs subgroups.</p
<p>Baseline demographic and clinicopathologic characteristics of the 796,335 study patients.</p
<p>Baseline demographic characteristics of all patients stratified by quintile of PCI rate.</p
Baseline characteristics in patients with the risk genotype or nonrisk genotype.</p
<p>Baseline Demographics of the Study Population Based on the rs2270915 Genotype.</p
<p>Baseline clinical and demographic characteristics of enrolled patients (n = 26).</p
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Data are expressed as mean and standard deviation for continuous variables (e.g. age) and as coun...
<p>Data are mean (SD) unless otherwise indicated.</p><p>Baseline patient characteristics.</p
<p>Data are shown as mean ± SD (95% confidence intervals) or n (%).</p><p>Baseline characteristics o...
<p>Baseline demographic and clinical characteristics of the study population (N = 342 patients).</p
<p>Results are expressed as mean (SD), median [interquartile range], or <i>absolute numbers of patie...
<p>Data are presented as mean ± standard deviation.</p><p>Baseline characteristics of the patients.<...
<p>Baseline demographics and disease characteristics of SSc patients (n = 31).</p
<p>Baseline demographic, diagnostic and clinical characteristics of the patients, by centre.</p
<p>Baseline characteristics for the patients in the <5 drugs and ≥5 drugs subgroups.</p
<p>Baseline demographic and clinicopathologic characteristics of the 796,335 study patients.</p
<p>Baseline demographic characteristics of all patients stratified by quintile of PCI rate.</p
Baseline characteristics in patients with the risk genotype or nonrisk genotype.</p
<p>Baseline Demographics of the Study Population Based on the rs2270915 Genotype.</p
<p>Baseline clinical and demographic characteristics of enrolled patients (n = 26).</p
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Data are expressed as mean and standard deviation for continuous variables (e.g. age) and as coun...
<p>Data are mean (SD) unless otherwise indicated.</p><p>Baseline patient characteristics.</p
<p>Data are shown as mean ± SD (95% confidence intervals) or n (%).</p><p>Baseline characteristics o...
<p>Baseline demographic and clinical characteristics of the study population (N = 342 patients).</p
<p>Results are expressed as mean (SD), median [interquartile range], or <i>absolute numbers of patie...
<p>Data are presented as mean ± standard deviation.</p><p>Baseline characteristics of the patients.<...
<p>Baseline demographics and disease characteristics of SSc patients (n = 31).</p
<p>Baseline demographic, diagnostic and clinical characteristics of the patients, by centre.</p
<p>Baseline characteristics for the patients in the <5 drugs and ≥5 drugs subgroups.</p
<p>Baseline demographic and clinicopathologic characteristics of the 796,335 study patients.</p
<p>Baseline demographic characteristics of all patients stratified by quintile of PCI rate.</p
DOI
Add to ORKG